Skip to main content
. 2021 Feb 5;54(1):36–44. doi: 10.5090/kjtcs.20.123

Table 3.

Clinical outcomes of patients in the survivor and non-survivor groups

Variable Survivors (n=33) Non-survivors (n=41) p-value
Successful ECMO weaning 21 (63.6) 10 (24.3) 0.001
Survival to hospital discharge 17 (51.5) -
Length of intensive care unit stay (day) 47.12±28.178 17.46±11.272 0.001
Length of hospital stay (day) 71.61±51.701 27.02±27.432 0.001
Duration of ECMO support (day) 28.67±24.441 9.27±6.527 0.001
ECMO mode change (veno-arterio-venous mode) 2 (6.0) 3 (7.3) 1.000
Duration of mechanical ventilation support 39.64±23.231 17.76±14.896 0.001
Cause of death (within 28 days of ECMO initiation)a)
Sepsis - 21 (51.2)
Multiple organ failure - 13 (31.7)
Bleeding/disseminated intravascular coagulation - 4 (9.7)
Respiratory failure - 1 (2.4)
Anoxic brain injury - 2 (4.8)
Complications of ECMO (in hospital)
Bleeding 15 (45.4) 10 (24.3) 0.057
Acute kidney injury 3 (9.0) 12 (29.2) 0.032
Brain hemorrhage 3 (9.0) 1 (2.4) 0.208
Leg ischemia 1 (3.0) 2 (4.8) 1.000

Values are presented as number (%) or mean±standard deviation.

ECMO, extracorporeal membrane oxygenation.

a)Causes of in-hospital death are shown in Supplementary Table 1.